Researchers have shared a groundbreaking development in cancer treatment research with new technology that can selectively target cancerous cells whilst sparing healthy tissue.
A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be capable of identifying and destroying cancer cells in humans, opening up new possibilities for targeted therapies.